Immuneering Corp (IMRX) has risen Wednesday morning, with the stock adding 3.89% in pre-market trading to 2.67. IMRX's short-term technical score of 2 indicates that the stock has traded less bullishly over the last month than 98% of stocks on the market. In the Biotechnology industry, which ranks 102 out of 146 industries, Immuneering Corp ranks higher than 1% of stocks. Immuneering Corp has fallen 61.06% over the past month, closing at $6.58 on February 21. During this period of time, the stock fell as low as $1.91 and as high as $7.68. IMRX has an average analyst recommendation of Buy. The company has an average price target of $16.86.
IMRX has an Overall Score of 33. Find out what this means to you and get the rest of the rankings on IMRX!